Few treatment options for growing population of drug users in Afghanistan

NewsGuard 100/100 Score

The New York Times examines the "growing drug addiction problem" in Afghanistan, where, in 2010, about 900,000 people, or seven percent of the adult population, were using drugs, according to the U.N. Office on Drugs and Crime. The newspaper notes "a recent report by the Ministry of Public Health in partnership with Johns Hopkins University ... found HIV present in about seven percent of drug users, double the figure just three years ago, said Dr. Fahim Paigham, who until recently directed the Ministry of Public Health's AIDS control program."

Many drug users "say they want to stop using, but treatment options are woefully few," the newspaper writes, adding, "The government, through some Afghan nonprofit groups, runs several detoxification centers and is building seven more, but the facilities offer almost no post-detoxification support and have a 92 percent relapse rate, according to the Ministry of Counternarcotics, which is involved in running them ... The most efficacious treatment -- opiate substitution therapy -- has been all but blocked by the ministry despite pleas from the Ministry of Public Health, whose doctors are worried about the rising incidence of HIV" (Rubin/Rahimi, 8/27).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Researchers receive NIH grant to help develop gene therapy for HIV